Israel - Ibrani - Ministry of Health

mediline ltd. - ferrous as iron iii hydroxide sucrose complex 100 mg / 5 ml - concentrate for solution for infusion - iron-sorbitol-citric acid complex - severe iron deficiency only when oral administration has been found impossible. in cases of gastro-intestinal malobsorption which rules out oral therapy, patients on dialysis treated with erythropoietin. the diagnosis of iron deficiency must be based on appropriate laboratory tests.

Israel - Ibrani - Ministry of Health

rekah pharmaceutical industry ltd, israel - sulphamethoxazole; trimethoprim - תרחיף - sulphamethoxazole 4 %; trimethoprim 0.8 % - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - antibacterial for treatment of infections due to susceptible micro-organisms in the upper and lower respiratory tract infections, urinary tract infections, gastro-intestinal tract infections.

Israel - Ibrani - Ministry of Health

rekah pharmaceutical industry ltd, israel - sulphamethoxazole; trimethoprim - קפליות - trimethoprim 160 mg; sulphamethoxazole 800 mg - sulfamethoxazole and trimethoprim - sulfamethoxazole and trimethoprim - antibacterial treatment in infections due to susceptible microorganisms in urinary, respiratory and gastro-intestinal tract or genital system infections.

Israel - Ibrani - Ministry of Health

astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.

Israel - Ibrani - Ministry of Health

sanofi israel ltd - cabazitaxel - תרכיז וממס להכנת תמיסה לאינפוזיה - cabazitaxel 60 mg / 1.5 ml - cabazitaxel - cabazitaxel - in combination with prednisone for the treatment of patients with metastatic hormone refractory prostate cancer (mhrpc) previously treated with a docetaxel-based treatment regimen

Israel - Ibrani - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Israel - Ibrani - Ministry of Health

pfizer pharmaceuticals israel ltd - sirolimus - תמיסה (פומי) - sirolimus 1 mg/ml - sirolimus - sirolimus - rapamune is indicated for the prophylaxis of organ rejection in adult patients at low to moderate immunological risk receiving a renal transplant. it is recommended that rapamune be used initially in combination with cyclosporine microemulsion and corticosteroids for 2 to 3 months. rapamune may be continued as maintenance therapy with corticosteroids only if cyclosporine can be progressively discontinued.

Israel - Ibrani - Ministry of Health

sanofi israel ltd - polystyrene sulphonate sodium - אבקה להכנת תרחיף - polystyrene sulphonate sodium 99.934 % - polystyrene sulfonate - polystyrene sulfonate - treatment of hyperkalemia.

Israel - Ibrani - Ministry of Health

promedico ltd - barium sulfate 80.9977 %w/w - suspension - barium sulfate with suspending agents - radiolography of the gastro-intestinal tract. for use in x-ray departments.

Israel - Ibrani - Ministry of Health

promedico ltd - barium sulfate - אבקה להכנת תרחיף - barium sulfate 96.476 %w/w - barium sulfate without suspending agents - barium sulfate without suspending agents - for rectal administration (enema) as a radio-opaque agent for x-ray visualisation of the lower gastro-intestinal tract. it is designed for both single contrast barium enema and air-double contrast enema usage.